2020
DOI: 10.1177/2051415820921312
|View full text |Cite
|
Sign up to set email alerts
|

Clinical recurrence of prostatic ductal adenocarcinoma in the anterior urethra

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…NEPC tends to metastasize to bone, lung, and liver, and urethra or bladder metastasis has not been reported [ 1 , 2 ]. Isolated metastasis or recurrence of PC in the intra-urinary tract is extremely rare, with only 15 cases reported previously [ 5 19 ] (Table 1 ); five had an origin in the prostatic ductal adenocarcinoma (PDC) and most of the rest were from adenocarcinomas with lower Gleason scores. On the other hand, in a study of 282 patients with secondary bladder neoplasms, 19% had PC-related secondary urinary bladder tumors [ 20 ], and 39% had urinary bladder metastases at autopsy [ 21 ], but the majority showed bladder-neck invasion.…”
Section: Discussionmentioning
confidence: 99%
“…NEPC tends to metastasize to bone, lung, and liver, and urethra or bladder metastasis has not been reported [ 1 , 2 ]. Isolated metastasis or recurrence of PC in the intra-urinary tract is extremely rare, with only 15 cases reported previously [ 5 19 ] (Table 1 ); five had an origin in the prostatic ductal adenocarcinoma (PDC) and most of the rest were from adenocarcinomas with lower Gleason scores. On the other hand, in a study of 282 patients with secondary bladder neoplasms, 19% had PC-related secondary urinary bladder tumors [ 20 ], and 39% had urinary bladder metastases at autopsy [ 21 ], but the majority showed bladder-neck invasion.…”
Section: Discussionmentioning
confidence: 99%